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negatively contribute to several major diseases of the developed world to include diabetes, cardiovascular
disease, and cancer. According to the CDC approximately 80% of African Americans > 1 years of age suffer
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whether hypovitaminosis D in the African American population contributes to increase incidents of vascular
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Methods: An extensive literature search was conducted in the databases of MEDLINE, CINAHL, Web of
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Results: All four articles found were cross-sectional in nature and therefore ranked “low” in quality of
evidence. Two studies used data from the National Center for Health Statistics and found an independent
inverse correlation between vitamin D levels and peripheral artery disease. A third study of ESRD patients
looked at the relationship between MMP-9, (a biomarker for vascular disease), and vitamin D levels and
found an inverse correlation. There was a positive correlation found in the study by Freedman et al. in regards
to vitamin D level and calcified atherosclerotic plaques (CP) in the carotid and infrarenal aorta, with no
association found between vitamin D and CP in the coronary vessels.
Conclusion: The findings deduced in this study, suggest that, there is not definitive data that supports as to
whether hypovitaminosis D negatively affects vascular health in African-Americans. It is well understood that
correlation does not imply causation. There is a need for longitudinal studies as well as random control trials.
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Abstract   
 
Background: There is growing concern that chronic hypovitaminosis D at levels below 30ng/ml 
may negatively contribute to several major diseases of the developed world to include diabetes, 
cardiovascular disease, and cancer. According to the CDC approximately 80% of African 
Americans > 1 years of age suffer from vitamin D insufficiency. The clinical question that will be 
explored in the following literature review is, whether hypovitaminosis D in the African 
American population contributes to increase incidents of vascular disease.  
Methods: An extensive literature search was conducted in the databases of MEDLINE, CINAHL, 
Web of Science, and Google Scholar. Articles were selected that specifically studied the African 
American population and assessed the relationship of vitamin D and vascular disease in that 
group.  
Results: All four articles found were cross-sectional in nature and therefore ranked “low” in 
quality of evidence.  Two studies used data from the National Center for Health Statistics and 
found an independent inverse correlation between vitamin D levels and peripheral artery disease. 
A third study of ESRD patients looked at the relationship between MMP-9, (a biomarker for 
vascular disease), and vitamin D levels and found an inverse correlation. There was a positive 
correlation found in the study by Freedman et al. in regards to vitamin D level and calcified 
atherosclerotic plaques (CP) in the carotid and infrarenal aorta, with no association found 
between vitamin D and CP in the coronary vessels.  
Conclusion: The findings deduced in this study, suggest that, there is not definitive data that 
supports as to whether hypovitaminosis D negatively affects vascular health in African-
Americans. It is well understood that correlation does not imply causation. There is a need for 
longitudinal studies as well as random control trials.  
Keywords: Vitamin D, African American, Vascular disease, Peripheral Artery Disease, and 
Cardiovascular disease. 
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Vitamin D Deficiency as a Cause of Increase Vascular Disease in African Americans  
 
BACKGROUND 
Introduction 
According to the CDC 2001 to 2006 National Center of Health Statistics (NCHS) 
approximates that one-third of all Americans aged one-year and over are vitamin D insufficient 
and of black Americans the number rises to 80%.1 Over the past 100 years there have been great 
improvements in nutrition with the fortification of foods with vitamin D and the once common 
pediatric infliction of rickets as almost been eliminated from the developed world. However, 
more recently towards the end of the 20th century, scientists have been exploring how vitamin D 
deficiency may contribute to extra-skeletal health such as cardiovascular disease, hypertension, 
diabetes, multiple sclerosis, and cancer. This research has led some in the medical community to 
question whether skeletal health should be the only biomarker for an appropriate vitamin D level 
should be especially, with the prevalence of vitamin D deficiency in the African American 
population.  
Vitamin D Basics 
Vitamin D insufficiency is defined as a concentration of 25-hydroxyvitamin D, 
(25(OH)D), between 20-30ng/ml (50-75 nmol/L) and deficiency below 20 ng/ml. 
Hypovitaminosis D is common and may affect more than one billion people worldwide.2 
Deficiency is known to cause rickets in children, accelerate age related bone loss, and as 
mentioned earlier, may be associated with nearly all major diseases of the developed world to 
include, cancer, immune diseases, and cardiovascular disease.3,4 Table 1 is from the National 
Institutes of Health and compares vitamin D with health status.   
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Recent data from National Health and Nutritional Exam Survey (NHANES) suggest that 
77% of the US population have plasma 25(OH)D levels of < 30 ng/ml. The prevalence of vitamin 
D deficiency is particularly high among African Americans, Hispanics, and Asians.5 There is 
some disagreement within the medical community with The Institute of Medicine’s defined 
parameters for vitamin D deficiency. The concern is that the present recommendation is old with 
skeletal health the only biomarker and that it falls short in appreciating the effects of vitamin D in 
extraskeletal health.6 
The main source of vitamin D is not from diet but rather from cutaneous production as a 
result of ultraviolet (UV) B photons. More than 90% of the vitamin D requirement for most 
people comes from casual exposure to sunlight.8 UVB radiation with a wavelength of 290–320 
nm penetrates uncovered skin and converts cutaneous 7-dehydrocholesterol to previtamin D3, 
which in turn becomes vitamin D3. Anything that influences the amount of exposure to UVB 
radiation ,(e.g. cloud cover, clothes, sun-block, etc.), alters the amount of pre-vitamin D3 being 
produced from 7-dehydrocholesterol. Latitudes above 37 ° enter a more oblique zenith angle, 
(angle of the earth in relationship to the sun), during the winter which reduces UVB photons by as 
much as 80-100% during the winter months.9 As Dr. James Dowd puts it, when the leaves change 
color and begin to fall during autumn, the available UVB is less and your serum vitamin D levels 
drop. For the places above 37° latitude, vitamin D stores are often depleted by January with diet 
being the sole source of replenishment.6 How much latitude plays a role in vitamin D level is 
controversial. Hagenau et al10 published a meta-analysis showing significant decline of vitamin D 
with latitude in Caucasians but no correlation between latitude and vitamin D deficiency in non 
Caucasians. Furthermore, as a person ages this situation becomes still more sensitive. Later in 
life, 7-dehydrocholesterol begins to decline putting older adults at increased risk for developing 
vitamin D insufficiency. As many as half of older adults in the United States with hip fractures 
could have serum 25(OH)D levels <12 ng/ml.7 
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 Lastly, distribution of melanosomes in skin is one of the largest determinants of vitamin 
D levels.11,12  Melanin evolved as an effective sunscreen, as it absorbs UVB photons. Compared 
with light skinned people, people with increased melanin pigmentation require longer exposure to 
sunlight to make the same amount of vitamin D3. The populations with the highest rate of 
vitamin D deficiency in America are Black Americans.7, 9, 11, 12 
Prevalence of vitamin D deficiency in the United States is on the rise despite efforts in 
food fortification. This decrease may be contributed to the change in lifestyle behavior, increase 
urbanization, rise in obesity, and dietary habits. In comparing the NHANES there was a marked 
decrease in serum 25(OH)D levels from the 1988-1994 survey to that of 2001-2004 NHANES 
data collection. Overall, the mean serum 25(OH)D level in the US population decreased from 30 
ng/ml to 24 ng/ml during the 2001-2004 collection.5 As described in the Figure 1, non-Hispanic 
blacks have the highest prevalence of low serum 25(OH)D concentrations.  
“As a vascular surgeon, I see more cases of high blood pressure (hypertension), stroke, 
and peripheral arterial disease (PAD) in African American adults,” said Leila Mureebe, MD, a 
vascular surgeon at Duke University Medical Center in North Carolina.13 African American 
adults are 40% more likely to have hypertension and are more likely to be diagnosed with 
coronary heart disease, and they are more likely to die from heart disease.13 
The link between hypovitaminosis D and vascular disease to include cardiovascular 
disease is somewhat controversial. In several large cohort studies there seems to be an 
independent association with hypovitaminosis and cardiovascular mortality.14,15,16 There is also 
evidence of increased vascular disease associated with hypovitaminosis in animal studies.17 But 
Rodriguez and colleagues in their cross-sectional study found that the mean plasma 25(OH)D was 
not significantly different between patients with acute coronary syndrome and the control.18 
Unfortunately, to date, there are no definitive random control trials showing a correlation.  Could 
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chronic hypovitaminosis D in African Americans be contributing to an increase prevalence of 
vascular disease? This is the question looked at set out in the following literature review.   
METHODS 
An extensive literature search was conducted in the databases of MEDLINE, CINAHL, 
Web of Science, and Google Scholar. Terms used during the search were “vitamin D”, “African 
American”, “vascular disease”, “peripheral artery disease”, and “cardiovascular disease”. The 
search was limited to English only text with an emphasis on human studies and anything older 
than 15 years was excluded. Reference lists of found articles were also reviewed to further select 
relevant articles. The articles were evaluated using the GRADEpro guidelines. 
RESULTS  
Articles were selected that specifically studied the African American population and 
assessed the relationship of vitamin D and vascular disease in that group. There were four original 
research articles found that qualified to address the clinical question; whether hypovitaminosis D 
in African Americans contributed to an increased incident of vascular disease. Two studies19,20 
used data from NHANES to evaluate whether there was a statistical association between PAD 
and vitamin D levels. Both studies did find an association in the general population study 
population however, in examining the subpopulation of African Americans, this association held 
for Reis et al20 but fell apart in the Melamed et al19 study. Association was further supported by 
the study by Wasse et al,21 which found an inverse correlation between vitamin D levels and 
MMP-9 (a biomarker for vascular disease), and there was also a positive correlation between 
25(OH)D and anti-inflammatory IL-10 in African American. Findings differed for Freedman en 
al22, this study found there was no association between 25(OH)D levels and CP in the coronary 
arteries and actually an increase in calcified atherosclerotic plaques (CP) in the infrarenal aorta 
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and carotid arteries with higher levels of vitamin D. See below and table 2 and 3 for further 
details of relevant studies.  
Serum 25-Hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: 
Rusults from NHANES 2001 to 2004   
Melamed et al19 conducted a secondary analysis of the cross-sectional study, NHANES, 
to assess whether the prevalence of PAD is statistically associated with serum 25(OH)D levels. 
Subgroup analysis of the study population was conducted. Non-Hispanic blacks were a sample 
size of 508 participants total with only 60 having PAD.19  
The National Health and Nutrition Examination Survey (NHANES) 2001 to 2004 was a 
nationally representative cross-sectional survey of the civilian noninstitutionalized United States 
population performed by the National Center for Health Statistics. Ankle-brachial index (ABI) 
was measured in NHANES 2001 to 2004 with participants ≥ 40 years of age. Serum 25(OH)D 
levels were measured for 4839 participants, ≥ 40 years of age, who had complete data on all other 
study variables. Study procedures in NHANES 2001 to 2004 consisted of an in-home interview 
followed by a medical evaluation and blood sample collection at a mobile examination center. 
Self reported race was categorized as non-Hispanic white, non-Hispanic black, Mexican-
American, and other. The NHANES 2001 to 2004 examination procedures included measurement 
of height, weight, and blood pressure.19  
 The primary outcome for the study was PAD defined using ABI. Participants with ABI ≥ 
1.5 may have severe arterial rigidity and were therefore excluded from analyses (n=10). PAD was 
defined as ABI <0.9. participant characteristics were calculated by PAD status. The statistical 
significance of differences for these characteristics was determined using least squares and 
minimum likelihood for continuous and dichotomous variables, respectively. Next, the 
prevalence of PAD was calculated by quartile of 25(OH)D, with the statistical significance of 
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trends across quartile assessed using maximum likelihood. Prevalence ratios of PAD associated 
with quartile of serum 25(OH)D were calculated using log binomial regression models. An initial 
model included adjustment for age, gender, and race-ethnicity with a subsequent model including 
additional adjustment for education, current and former cigarette smoking, leisure-time physical 
activity, diabetes mellitus, total to HDL cholesterol ratio, body mass index, systolic blood 
pressure, log homocysteine, glycohemoglobin, statin use, antihypertensive medication use, 
vitamin D supplement use, history of myocardial infarction, elevated CRP, and chronic kidney 
disease. The multivariable-adjusted association between 25(OH)D , as continuous variable, and 
PAD was determined overall and for subgroups defined by age, gender, race-ethnicity, BMI, 
physical activity, diabetes mellitus, a history of myocardial infarction, chronic kidney disease, 
and vitamin D supplement use. Differences in the association of 25(OH)D and PAD across 
subgroup were tested by using a multiplicative term in the regression models. Data were analyzed 
using SUDAAN to account for the complex NHANES sampling design including unequal 
probabilities of selection, oversampling, and nonresponse. 19  
Overall, in the total population, there was a strong, graded association between lower 
levels of 25(OH)D levels and PAD. However this correlation was not found in the Non-Hispanic 
black population with the prevalence crossing 1 ranging from 0.81-1.53. Refer to table 2 and 3 for 
further analysis of the study. 19  
Differences in Vitamin D status as a possible contributor to the racial disparity in 
peripheral arterial disease 
 A cross-sectional study using data from the NHANES was conducted by Reis et al.20 A 
total of 3557 white and 1187 black adults aged ≥ 40 years completed a health examination as part 
of NHANES 2001-2004. Those who did not complete ABI testing or who were missing 25(OH)D 
information were excluded. The population size was 866 black adults was formed. The study goal 
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was of establishing whether there is a correlation with PAD and serum 25(OH)D. PAD was 
determined by an arterial brachial index (ABI) of less than 0.9. Information on smoking, alcohol 
use, physical activity, vitamin-mineral supplementation, mobility limitation, education, and 
household income was obtained by self-report.20  
All analyses were weighted to the US population to provide nationally representative 
estimates. SAS-callable SUDAAN statistical software was used to account for the complex 
survey design, a stratified multistage cluster sample. Because the concentrations of 25(OH)D and 
the prevalence of PAD differed significantly between the races, they examined predictors of 
25(OH)D and risk factors for PAD separately by race. Differences in sample characteristics 
according to race and presence of PAD were determined with independent sample t test for 
continuous measures and with chi-square tests for categorical measures. Race-specific odds ratios 
(Ors) (and 95% CIs) for PAD according to 25(OH)D concentration were estimated by using 
multivariate logistic regression models. Tests for a linear trend were performed by entering the 
continuous 25(OH)D variable into the multivariate model as an ordinal term.  The researchers 
found greater association of PAD with lower concentrations of serum 25(OH)D and lower 
association of PAD with higher serum concentrations. Refer to table 2 and 3 for further analysis 
of the study. 20  
25-hydroxyvitamin D concentration is inversely associated with serum MMP-9 in a cross-
sectional study of African American ESRD patients 
Wasse et al21 conducted a cross-sectional study of African Americans with end stage 
renal disease in the interest of determining whether 25(OH)D is associated with matrix 
metalloproteinase (MMP) levels (a biomarker for vascular disease). Adult ESRD patients 
receiving in-center maintenance hemodialysis at one of six Emory University-affiliated Davita 
dialysis centers in the fall of 2008, were eligible to enroll in the study. The study was limited to 
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African-Americans. All assessments were conducted at a single baseline visit. Several covariates 
were analyzed to include, age, gender, self-reported race, length of time on dialysis, body mass 
index, smoking status, vascular access type (arteriovenous fistula, arteriovenous graft, central 
venous catheter), season of blood collection, and activated vitamin D treatment. All patients 
received hemodialysis treatment three times per week. Categorcal variables ere reported by using 
the number of percent of observations. Continuous variables were expressed as means with 
standard deviations. For comparative evaluations, Chi-square tests (Fisher’s exact test when 
appropriate) and student unpaired independent t tests were performed for categorical and 
continuous variables, respectively. Associations between 25(OH)D and biomarker concentrations 
were first estimated in univariate analyses using Pearson’s correlation coefficients and 
corresponding P values. To adjust for possible confounding of these associations, multivariate 
linear regression models were used. Results were stratified by vascular access type. Two-tailed P 
values P < 0.05 were considered statistically significant. All analyses were performed using SAS 
version 9.2.21 
There were 91 participants. They found a significant inverse correlation with MMP and 
25(OH)D (p=0.004). In the univariate analyses and compared to patients with 25(OH) D ≥ 15 
ng/ml, MMP-9 and CRP concentrations were significantly greater among subjects with 25(OH)D 
< 15 ng/ml. The remaining inflammatory markers were not associated with 25(OH)D categories. 
Difference in MMP-9 concentration between the lowest and highest 25(OH)D groups were 
compared. Compared to the highest group and after adjustment for smoking, gender, BMI, age, 
diabetes, season and activated vitamin D treatment, the log MMP-9 concentration was greater in 
the lowest 25(OH)D group (P= 0.046). For every unit increase in 25(OH)D concentration, there 
was a logarithmic increase in anti-inflammatory IL-10 concentration of 0.02 pg/ml (p=0.04). 
Refer to table 2 and 3 for further analysis of the study. 21  
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Vitamin D, Adiposity, and Calcified Atherosclerotic Plaque in African-Americans 
 Freedman et al22 conducted a cross-sectional study of 340 African Americans with type II 
diabetes. In this study they examined whether there is a correlation with 25(OH)D and 1,25 
dihydroxyvitamin D levels, and calcified atherosclerotic plaque (CP), bone density, and fat 
volumes. Intact parathyroid hormone (PTH) and C-reactive protein were also examined. African-
Americans with type 2 diabetes recruited in the African American-Diabetes Heart Study formed 
the study population. Examinations were conducted in the General Clinical Research Centers of 
the Wake Forest University School of Medicine. Calcified atherosclerotic plaque was measured 
in the coronary, carotid, and infrarenal abdominal aorta arteries with single and multidetector CT 
systems using a standard electrocardiogram-gated CY scanning protocol based on those currently 
implemented in the National Heart, Lung, and Blood Institue’s Multi-Ethnic Study of 
Atherosclerosis (MESA). The calcium mass score was used for comparability between vascular 
territories.22 
 Generalized linear models were fitted to test for associations between circulation 
25(OH)D, 1,25 dihydroxyvitamin D, hsCRP, and intact parathyroid hormone (PTH) treated 
separately as predictors with PAD, aorta, coronary, and carotid artery CP. The Box-Cox method 
was applied to identify the appropriate transformation of each outcome variable that would best 
approximate the distributional assumptions of conditional normality and homogeneity of variance 
of the residuals. The natural log of (coronary CP +1), (carotid CP +1), (aorta CP + 1) were 
analyzed. Analyses were run without adjustment, adjusting for age and gender and adjusting for 
age, gender, body mass index, GFR, and Hemoglobin A1C. Standard regression diagnostics for 
collinearity and influence were computed for each model reported.22 
They found no association with 25(OH)D and coronary CP. However, there was a 
positive association with serum 25(OH)D concentrations and atherosclerotic plaque in the carotid 
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and infrarenal aorta (p=0.013 and 0.014 respectively). Refer to table 2 and 3 for further analysis 
of the study. 22   
DISCUSSION 
The clinical question of whether hypovitaminosis D in African Americans contributes to 
vascular disease is not easily answered but given the present studies there does seem to be a 
correlation with the strongest evidence coming from the Wasse et al21 However, there may also 
be a harmful association with higher vitamin D levels in regards to vascular health as 
demonstrated by Freedman et al22 As a clinician, to support vascular health without the 
significantly increasing the risk of atherosclerotic plaques, there appears to be enough evidence 
that supports the value of maintaining vitamin D levels at a conservative level between 50nmol/L 
-75nmol/L in African American patients. It should be emphasized that there is still need for 
longitudinal studies as well as randomized control trials looking specifically at this population 
especially to explore the efficacy of vitamin D supplementation on extraskeletal health and 
appropriate serum levels.  
Serum 25-Hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial 
Disease: Results from NHANES 2001 to 2004 
This cross-sectional study19 found a graded association between lower 25(OH)D levels 
and a higher prevalence of PAD. This association was present after age, gender, race-ethnicity, 
and multivariable adjustment. The sample size for African Americans (identified as non-Hispanic 
black) comprised of approximately 25% of the total population. The prevalence ratio for PAD in 
the subpopulation of African Americans was 1.11 (0.81-1.53) and since it crosses zero no 
correlation can be made in this specific group despite the affirmative results of the Caucasian 
group.  Potential limitations most notably, the study was cross-sectional. As any cross-sectional 
study, one must be cautious interpreting the direction of the association. An additional limitation 
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is the lack of data in NHANES on sun exposure, geographic location, and the season during 
which participants attended their study visits a cross-sectional study the quality of evidence is 
rated low.  
Differences in Vitamin D status as a possible contributor to the racial disparity in 
peripheral arterial disease 
Again using data from the NHANES 2001-2004, (nationally representative cross-
sectional survey of the civilian noninstitutionalized United States population), Reis et al20 
conducted a cross-sectional study and found similar results to that of Melamed et al.19 Reis et al20 
showed that African-Americans are 33% more likely to develop PAD than Caucasians even after 
adjusting for know confounders.  They concluded that their findings suggest that the high 
frequency of vitamin D deficiency observed in black adults may be an important contributor to 
higher risk of PAD. As a cross-sectional study the quality of evidence is low. Limitations of the 
study are similar to that of Melamed et al20 with the study being a cross-sectional. There was no 
data in NHANES on sun exposure, geographic location, and the season during which participants 
attended their study visit.  As a cross-sectional study the quality of evidence is rated low.  
25-hydroxyvitamin D concentration is inversely associated with serum MMP-9 in a cross-
sectional study of African American ESRD patients 
This cross-sectional study21 of 91 African Americans with ESRD was performed with a 
strong inverse correlation of MMP-9 and 25(OH)D (r=-0.29, p= 0.0004). Secondly there is a 
dose-response gradient, for every unit increase in 25(OH)D concentration, there was a log 
decrease in pro-inflammatory MMP-9 concentration of 0.018 pg/ml (p=0.03). With the dose-
response gradient the study is may be upgraded from a low quality to moderate level (further 
research is likely to have an important impact on our confidence in the estimate of effect and may 
change the estimate) but due to the number of participants and lack of follow up the study 
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remains at low quality. Limitations include small sample size, cohort limited to ESRD patients, 
and cross-sectional design of study does not allow for causal inference. As a cross-sectional study 
the quality of evidence is rated low.  
Vitamin D, Adiposity, and Calcified Atherosclerotic Plaque in African-Americans 
 This cross-sectional study22 most closely met the clinical question by examining calcified 
atherosclerotic plaques in African Americans and drawing on whether there is a relationship 
between this vascular disease and vitamin D deficiency. An important observation of the study 
was that a positive relationship with atherosclerotic plaques in the carotid and infrarenal arteries 
and serum 25(OH)D levels and, no association found in coronary arteries. This was only a cross-
sectional study and as such has limitations. An important limitation of this study was the cross-
sectional nature of the CT-derived measurements of CP meaning, that examination of CP was 
limited to a single plane. Secondly, the population was only that of African American’s with type 
II diabetes. Finally, as a cross-sectional design the study does not allow for causal inference 
therefore the quality of evidence is rated low. 
CONCLUSION 
The findings deduced in this study, suggest that, there is not definitive data with strong 
evidence that supports that hypovitaminosis D negatively affects vascular health in African-
Americans. There does seem to be a correlation between hypovitaminosis D and vascular health 
(especially in the Caucasian population) but to what extent is uncertain. There is a need for 
longitudinal studies as well as randomized control trials evaluating whether treatment of 
hypovitaminosis D improves vascular outcomes. It is well understood that correlation does not 
imply causation. Normal serum concentrations of 25-hydroxyvitamin D may differ based on 
ethnicity and needs to be determined in the African-American population. Long-term safety 
studies need to be performed on the effect of supplementing vitamin D in African-Americans 
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with known deficiency. Vitamin D is an inexpensive supplement that could have a significant role 
in bridging the health disparity gap between white and black Americans.  
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Table 1: Serum 25(OH)D Concentrations and Health1 
nmol/L** ng/mL* Health status 
<30 <12 Associated with vitamin D deficiency, leading to rickets in infants and children and osteomalacia in adults 
30–50 12–20 Generally considered inadequate for bone and overall health in healthy individuals 
≥50 ≥20 Generally considered adequate for bone and overall health in healthy individuals 
>125 >50 Emerging evidence links potential adverse effects to such high levels, particularly >150 nmol/L (>60 ng/mL) 
*   Serum concentrations of 25(OH)D are reported in both nanomoles per liter (nmol/L) and nanograms per milliliter (ng/mL).   
** 1 nmol/L = 0.4 ng/mL 
Table II. Characteristics of Reviewed Studies 
 
Table 2 Characteristics of Reviewed Studies                          Quality Assessment  
Importance Study Study 
Design 
Sampling Screening Test Methodology Sampling 
Population 
Sampling 
Process 
Indirectness Quality 
Melamed et 
al19 
Cross-
Sectional  
Second 
Analysis 
NHANES 
White and 
Black adults. 
Age ≥ 40 
years.  
Arterial Brachial 
index (ABI).  
Serum 25-
hydroxyvitamin D 
No Control Limited to 
participants 
of NHANES  
Participants 
of 
NHANES 
Design of 
study does 
not allow for 
causal 
inference 
Low Similar findings to 
that of other cross-
sectional studies for 
white Americans. 
Study lacked power 
for African 
Americans 
Reis et al20 Cross-
Sectional 
Second 
Analysis 
NHANES 
White and 
Black adults. 
Age ≥ 40 
years.  
Arterial Brachial 
index (ABI).  
Serum 25-
hydroxyvitamin D 
No Control Limited to 
participants 
of NHANES 
Participants 
of 
NHANES 
Design of 
study does 
not allow for 
causal 
inference 
Low These findings 
suggest that the high 
frequency of 
vitamin D 
deficiency observed 
in black adults may 
be an important 
contributor to their 
higher risk of PAD. 
Wasse et 
al21 
Cross-
Sectional 
African 
Americans 
with End 
Stage Renal 
Disease 
(ESRD).  
Serum 25-
hydroxyvitamin D 
and 
metalloproteinases 
(MMP’s) 
No Control ESRD 
patients not 
representative 
of general 
population. 
Limited to 
six dialysis 
centers in 
Georgia  
Surrogate 
outcome use 
of MMP 
biomarker.  
Design of 
study does 
not allow for 
causal 
inference 
Low MMP’s serve as an 
important biomarker 
in extracellular 
matrix remodeling.  
 
25(OH)D 
concentration was 
inversely and 
significantly 
correlated with 
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MMP 
Freedman et 
al22 
Cross-
Sectional 
African 
Americans 
with type 2 
diabetes. Age 
median 54. 
Vascular imaging 
with CT 
Serum 25(OH)D 
and 1,25 
dihydroxyvitamin 
D. 
No Control Type 2 
diabetic 
patients not 
representative 
of gen. 
population 
Limited to 
Wake 
Forest 
University 
School of 
Medicine  
Design of 
study does 
not allow for 
causal 
inference 
Low Results contradict 
what has been 
observed in 
individuals of 
European descent. 
Table II. Summary of Findings 
 
Study Outcome 
Measurements 
Results Relative 
Risk 
No. of 
Participants 
Quality of 
evidence 
Melamed et al19 Peripheral Arterial 
Disease associated with 
vitamin D level 
Prevalence ratio: 
1.11 (0.81-1.53) 
n/a Non-Hispanic 
black (n=511) 
Low 
Reis et al20 Peripheral arterial 
disease associated with 
vitamin D level 
Excess odds f 33% 
difference between 
black and white 
subjects.  
The odds 
of PAD 
2.11 (95% 
CI: 1.55, 
2.87) times 
as high in 
black 
adults 
Non-Hispanic 
black (n=866) 
Low 
Wasse et al21 MMP-9 association 
with vitamin D level  
Pearson correlation 
coefficient -0.29, P 
value = 0.004 
n/a 91 African 
Americans  
with ESRD 
Low 
Freedman et 
al22 
Calcified 
atherosclerotic plaque.  
Positive association 
between vitamin D 
and aorta and 
carotid artery 
calcified 
atherosclerotic 
plaque (P= 0.013 
and 0.014 
respectively) but 
not with coronary 
artery CP or bone 
density.  
n/a 340 African 
Americans 
with type 2 
diabetes 
mellitus. 
Low 
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FIGURES 
Figure 1: presents the prevalence of insufficiency in the U.S. adults (≥ 60 years) in according to 
the present parameters. 
 
Figure 2. McAuley D. Vitamin D. The clinician’s ultimate reference. . http://www.globalrph.com /vitamin_d.htm. Last modified 
September 2011. Accessed January 19, 2012  
  25  
 
 
 
 
 
